Publicaciones en colaboración con investigadores/as de Hospital de Mataró (29)

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  3. Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

    European Journal of Internal Medicine, Vol. 125, pp. 51-56

2023

  1. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

2022

  1. Validation of the Spanish Activity Questionnaire in COPD (SAQ-COPD) in Patients with Chronic Obstructive Pulmonary Disease

    International Journal of COPD, Vol. 17, pp. 2835-2846

2021

  1. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416

2020

  1. Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update

    Archivos de Bronconeumologia

  2. Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)

    BMC Infectious Diseases

  3. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

  4. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

  3. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

    Journal of Infection, Vol. 79, Núm. 4, pp. 300-311

2018

  1. A Composite of Functional Status and Pneumonia Severity Index Improves the Prediction of Pneumonia Mortality in Older Patients

    Journal of General Internal Medicine, Vol. 33, Núm. 4, pp. 437-444

  2. Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ≥65 years hospitalised due to community-acquired pneumonia

    Epidemiology and Infection, Vol. 146, Núm. 14, pp. 1870-1877

  3. Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain

    Journal of Asthma, Vol. 55, Núm. 4, pp. 391-401

  4. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

    Journal of Thrombosis and Thrombolysis, Vol. 46, Núm. 4, pp. 551-558

  5. Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice

    Archivos de Bronconeumologia, Vol. 54, Núm. 9, pp. 467-475

  6. Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study

    ERJ Open Research, Vol. 4, Núm. 4

  7. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study

    CMAJ, Vol. 190, Núm. 1, pp. E3-E12